The clinical guideline for CG133 Self-harm in over 8s: long-term management has been checked by NICE for the need for update.
Registered stakeholders for the guideline are invited to comment on the provisional decision via this website. Please see the consultation page for more details.
Review decision date: August 2014
Following the recent surveillance review which checks the need to update CG133, this guideline should not be updated at this time. This guideline will be checked again for update at its scheduled time point according to the methods described here.
Next review date: September 2016
This clinical guideline offers evidence-based advice on the longer-term treatment and management of self-harm. It follows on from self-harm: the short-term physical and psychological management and secondary prevention of self-harm in primary and secondary care (NICE guideline CG16), which covered the treatment of self-harm within the first 48 hours of an incident.
This guideline was previously called self-harm: longer-term management.
The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals are expected to take this guideline fully into account, alongside the individual needs, preferences and values of their patients or service users. The application of the recommendations in this guideline is not mandatory and the guideline does not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or their carer or guardian.
Local commissioners and/or providers have a responsibility to enable the guideline to be applied when individual health professionals and their patients or service users wish to use it. They should do so in the context of local and national priorities for funding and developing services, and in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Nothing in this guideline should be interpreted in a way that would be inconsistent with compliance with those duties.